1763 — China Isotope & Radiation Cashflow Statement
0.000.00%
Last trade - 00:00- HK$6.77bn
- HK$10.30bn
- CNY7.57bn
- 49
- 68
- 93
- 84
Annual cashflow statement for China Isotope & Radiation, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | R2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 596 | 803 | 921 | 922 | 1,045 |
| Depreciation | |||||
| Non-Cash Items | -30.3 | -43.6 | -31.6 | -140 | 37.5 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -446 | -162 | -249 | -962 | -1,185 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 292 | 794 | 863 | 85 | 142 |
| Capital Expenditures | -410 | -428 | -576 | -898 | -1,032 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -14 | -480 | 45.5 | 468 | 467 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -424 | -907 | -531 | -430 | -565 |
| Financing Cash Flow Items | 40.2 | -103 | -102 | -169 | 282 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -156 | -97.4 | -238 | 484 | 500 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -289 | -210 | 93.7 | 140 | 74.7 |